Fig. 2From: Validation of the graded prognostic assessment for lung cancer with brain metastases using molecular markers (lung-molGPA)Actuarial survival of patients with non-adenocarcinoma stratified by Lung-molGPA, p = 0.0001 (pooled over all strata)Back to article page